Day: December 23, 2024

First Busey Corporation and CrossFirst Bankshares, Inc. Announce Shareholder Approvals of Merger

Written by Customer Service on December 23, 2024. Posted in Mergers And Acquisitions.

CHAMPAIGN, Ill. and LEAWOOD, Kan., Dec. 23, 2024 (GLOBE NEWSWIRE) — First Busey Corporation (“First Busey”) (Nasdaq: BUSE), the holding company of Busey Bank, and CrossFirst Bankshares, Inc. (“CrossFirst”) (Nasdaq: CFB), the holding company of CrossFirst Bank, today jointly announced that First Busey shareholders and CrossFirst shareholders have each voted to adopt and approve, as applicable, all proposals relating to the previously announced merger in which First Busey will acquire CrossFirst. The special shareholder meetings were held on Friday, December 20, 2024. “Our shareholders’ overwhelming approval of this business combination is an important milestone in the process of closing this transaction,” said First Busey Chairman and CEO Van Dukeman. “This approval reflects our shareholders’ confidence in this compelling merger...

First Busey Corporation and CrossFirst Bankshares, Inc. Announce Shareholder Approvals of Merger

Written by Customer Service on December 23, 2024. Posted in Mergers And Acquisitions.

TX Rail Products, Inc. Reports Revenue Growth of 16% for Fiscal 2024

Written by Customer Service on December 23, 2024. Posted in Earnings Releases And Operating Results.

Gross Profit Margin Increases; Net Income Doubles ASHLAND, Ky., Dec. 23, 2024 (GLOBE NEWSWIRE) — TX Rail Products, Inc. (OTC Markets PINK: TXRP), a supplier of rail and rail products to the U.S. coal mining industry, short line railroads and tunneling contractors, today announced financial results for its fiscal year 2024. Mr. Shrewsbury, CEO and Chairman of TX Rail Products, Inc., commented, “For fiscal year 2024, we delivered double-digit revenue growth of 16% and with disciplined cost management, we more than doubled our net income. Importantly, we are generating positive cash from operations, thereby strengthening our balance sheet, self-funding our business and enabling the repurchase of our common stock.” Shrewsbury continued, “Demand remains robust for our rail products, as our reputation for excellent customer service combined...

Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement

Written by Customer Service on December 23, 2024. Posted in Mergers And Acquisitions.

Inmagene Biopharmaceuticals is a clinical stage company focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody with an extended half-life and a silenced ADCC function The transaction is expected to result in approximately $175 million to support further development of IMG-007, including $75 million from an oversubscribed Private Placement that will close immediately following the merger The Financing includes both new investors such as Deep Track Capital, Foresite Capital, RTW Investments, and existing Ikena investors such as BVF Partners L.P., Blue Owl Healthcare Opportunities, Omega Funds, and OrbiMed The transaction is expected to close in mid-2025 BOSTON, Mass. and SAN DIEGO, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,”) and Inmagene Biopharmaceuticals (“Inmagene”)...

APA Corporation Announces Results of Private Exchange Offers, Tender Offers, and Consent Solicitations at Extended Early Consent Date and Upsizing of Tender Offers

Written by Customer Service on December 23, 2024. Posted in Public Companies.

HOUSTON, Dec. 23, 2024 (GLOBE NEWSWIRE) — APA Corporation (“APA”) (Nasdaq: APA) announced today the extended early results as of 5:00 p.m., New York City time, on December 20, 2024 (the “Extended Early Consent Date”) of the previously announced (i) offers to exchange (the “Exchange Offers”) any and all validly tendered and accepted notes and debentures listed in the table below issued by Apache Corporation, its wholly-owned subsidiary (“Apache”), for new notes to be issued by APA (the “APA Notes”), (ii) offers to purchase for cash (the “Tender Offers” and together with the Exchange Offers, the “Offers”) up to $1,000,000,000 aggregate principal amount of any and all validly tendered and accepted Apache Notes of certain series (the “Apache Tender Notes”), and (iii) solicitations of consents (the “Consent Solicitations”) to certain...

iLearningEngines Voluntarily Initiates Chapter 11 Proceedings

Written by Customer Service on December 23, 2024. Posted in Public Companies.

Company Seeks To Reorganize Its Finances While Continuing to Operate Its Business BETHESDA, Md., Dec. 23, 2024 (GLOBE NEWSWIRE) — iLearningEngines, Inc. (NASDAQ: AILE) (“iLearningEngines,” “ILE” or the “Company”), a leader in AI-powered learning and work automation, today announced that on December 20, 2024 the Company voluntarily initiated Chapter 11 proceedings in the United States Bankruptcy Court for the District of Delaware (the “Court”). The Company will seek Court approval to continue operating on a business as usual basis during the proceedings and intends to continue to provide support to its installed customer base that relies on its Applied AI platform to run their businesses. “We appreciate the continued support of our customers, partners and employees, and our hope is that this process will put us in a better position...

VERSES Renews Agreement with Chief Scientist Karl Friston to Continue Innovation

Written by Customer Service on December 23, 2024. Posted in Public Companies.

Multi-year Contract Builds on Success in Genius™ and Atari Benchmarks for Next-Gen AI VANCOUVER, British Columbia, Dec. 23, 2024 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation intelligent systems, announces that the Company has extended its exclusive contract with Professor Karl Friston, acclaimed neuroscientist, to continue his role as Chief Scientist. The extension includes additional performance-based incentives that recognize recent breakthroughs in research and development and contributions to its flagship product Genius™ and further expected technological advancements. “Our work with Professor Friston has exceeded our expectations,” said Gabriel René, founder and CEO of VERSES. “His revolutionary...

Yara International ASA: mandatory notification of trade

Written by Customer Service on December 23, 2024. Posted in Public Companies.

Yara has today transferred to Fernanda Lopes Larsen, Yara EVP, Africa & Asia, member of Yara’s Group Executive Board, a total of 2,129 Yara shares (ticker: YAR, ISIN: NO0010208051) at an average price of NOK 305.30 per share. Following this purchase, Fernanda Lopes Larsen owns a total of 13,915 shares in Yara international ASA. In order to support alignment between members of the Group Executive Board and shareholder interests, it is expected that members of the Group Executive Board participating in Yara’s Share Based Remuneration program (SBR), in addition to the shares received as part of the SBR, invest in Yara shares an amount equalling the lowest amount received as net, after tax short-term incentive plan payout for the preceding year or the net amount received as SBR for the relevant year, and do so yearly as a...

Ocean Power Technologies Readies Shipment of AI Capable Merrows™ PowerBuoy® for Naval Postgraduate School

Written by Customer Service on December 23, 2024. Posted in Public Companies.

Main Assembly Finalized–Further Progressing Strategic Plan MONROE TOWNSHIP, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced it has finalized the main assembly of the previously announced PowerBuoy® for Naval Postgraduate School. The full system, which includes installing AT&T® 5G technology and integrating advanced subsea sensors into a PowerBuoy® equipped with OPT’s latest Merrows™ suite for AI capable seamless integration of Maritime Domain Awareness (MDA) across platforms, is now being readied for shipment ready for deployment in early 2025 alongside the Technology Showcase NPS is hosting in January. Once deployed, the PowerBuoy®...

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

Written by Customer Service on December 23, 2024. Posted in Public Companies.

Company Expected Notice for Continued Deficiency and Delist Letter from the Nasdaq Stock Market Company Intends to Request Hearing to Appeal in a Timely Manner MIRAMAR, Fla., Dec. 23, 2024 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported on December 17, 2024, the Company received written notice from the Listing Qualifications Staff (“Staff”) that it had failed to re-gain compliance for continued listing requirements of the Nasdaq Global Markets. As previously disclosed, on June 20, 2024, the Company received written notice from the Staff, which notified the Company that, for the 30...

Day: December 23, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals